Advertisement
Advertisement

JNJ

JNJ logo

Johnson & Johnson

234.54
USD
Sponsored
-4.13
-1.73%
Apr 16, 16:00 UTC -4
Closed
exchange

After-Market

234.59

+0.06
+0.02%

JNJ Earnings Reports

Positive Surprise Ratio

JNJ beat 35 of 41 last estimates.

85%

Next Report

Date of Next Report
Jul 14, 2026
Estimate for Q2 26 (Revenue/ EPS)
$25.29B
/
$2.87
Implied change from Q1 26 (Revenue/ EPS)
+5.11%
/
+6.30%
Implied change from Q2 25 (Revenue/ EPS)
+6.52%
/
+3.61%

Johnson & Johnson earnings per share and revenue

On Apr 14, 2026, JNJ reported earnings of 2.70 USD per share (EPS) for Q1 26, beating the estimate of 2.69 USD, resulting in a 0.32% surprise. Revenue reached 24.06 billion, compared to an expected 23.87 billion, with a 0.82% difference. The market reacted with a +0.90% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 15 analysts forecast an EPS of 2.87 USD, with revenue projected to reach 25.29 billion USD, implying an increase of 6.30% EPS, and increase of 5.11% in Revenue from the last quarter.
FAQ
For Q1 2026, Johnson & Johnson reported EPS of $2.70, missing estimates by 0.32%, and revenue of $24.06B, 0.82% above expectations.
The stock price moved up 0.9%, changed from $237.96 before the earnings release to $240.10 the day after.
The next earning report is scheduled for Jul 14, 2026.
Based on 15 analysts, Johnson & Johnson is expected to report EPS of $2.87 and revenue of $25.29B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement